scholarly journals Influence of YEA-SACC 1026 Probiotic on Some Production and Consumption Indices in Chicken Broilers

2017 ◽  
Vol 74 (1) ◽  
pp. 37
Author(s):  
Ionel TOADER ◽  
Aurel SARA ◽  
Mihai BENTEA ◽  
Marius CIOLTEA
Keyword(s):  
Body Weight ◽  
Phase I ◽  
Phase Ii ◽  
Average Daily Gain ◽  
Phase Iii ◽  
Production And Consumption ◽  
Daily Gain ◽  
Average Body ◽  
Average Body Weight

The researches followed the effects of powderYEA-SACC 1026 probiotic on some production and consumption indices in chicken broilers. The researches were effected on 75 meat chickens of Ross-308 hybrid, which were grouped in three lots of 25 capita/lot during 42 days. In the lot L1(E), for 42 days, in the mixed fodder was added YEA-SACC 1026 probiotic in proportion of 0.1% in breeding phase I (1-14 days), of 0.1% in phase II (15-35 days) and 0.1% in phase III (36-42 days). In the lot L2(E), for 42 days, in the mixed fodder was added YEA-SACC 1026 probiotic in proportion of 0.25% in breeding phase I (1-14 days), of 0.25% in phase II (15-35 days) and 0.25% in phase III (36-42 days). The chickens of all lots were weighted at the beginning of experiment and after that weekly being calculated the average body weight, average daily gain, fodder intake and fodder conversion index. The use of y YEA-SACC 1026 probiotic in lot L1(E) determined an increase of body weight with 16.26%, of average daily gain with 15.55% and the fodder conversion index was reduced with 29.16% given to Control Lot L(M). On the second place was situated the lot L2(E), in witch was administered 0.25% of YEA-SACC 1026 probiotic, with an increase of body weight of 8.32%, of average daily gain with 7.54% and the fodder conversion index was reduced with 21.78% given to Control Lot L(M). These superior results, registered in meat chickens from lot L1(E) YEA-SACC 1026 probiotic 0.1% and lot L2(E) YEA-SACC 1026 probiotic 0.25%, confirm the favourable influence of this probiotic on chicken broilers’ performances.

scholarly journals Frequência de suplementação proteico-energética sobre o desempenho e comportamento ingestivo de bezerros Nelore mantidos em pastagem tropical na estação seca

2018 ◽  
Vol 39 (6) ◽  
pp. 2555
Author(s):  
Gumercindo Loriano Franco ◽  
Marcelo Vedovatto ◽  
Marcella Cândia D'Oliveira ◽  
Ibrahim Miranda Cortada Neto ◽  
Maria Da Graça Morais ◽  
...  
Keyword(s):  
Body Weight ◽  
Average Daily Gain ◽  
Ingestive Behavior ◽  
Animal Performance ◽  
Urochloa Brizantha ◽  
Daily Gain ◽  
Average Body ◽  
Average Body Weight

With the objective to evaluate different frequencies of supplementation on the performance and ingestive behavior of Nellore calves kept on Urochloa brizantha cv. Marandu pasture, 56 animals with initial average body weight (BW) of 174.5 kg were submitted to the following treatments: no supplement and 1x, 3x, and 7x supplementation per week. The supplement was provided in the amount of 3.5 g kg-1 of BW day-1. BW and evaluation of behavior were assessed every 28 days. The randomized block's design with two repetitions was used. The analyses of variance were carried out by the GLM procedure in the SAS software, and the means were compared by the Tukey’s test at 5% significance. The supplementation increased the average daily gain (ADG; P ? 0.05); however, it did not differ between frequencies (0.005, 0.190, 0.183, and 0.177 kg head-1 day for the no supplement treatment and 1x, 3x, and 7x per week, respectively). The animals in the no supplement treatment showed longer grazing time (P ? 0.05) compared to those receiving the supplement. However, results did not differ between frequencies (10.44, 8.57, 8.32, and 8.59 hours day-1 for no supplement treatments and 1x, 3x, and 7x per week, respectively). Thus, the frequency of supplementation can be reduced to once a week without reducing animal performance.

scholarly journals Performance and Diet Digestibility of Male Garut Lamb Fed Ipomea reptans Seed

2018 ◽  
Vol 42 (4) ◽  
Author(s):  
Mohamad Haris Septian ◽  
Iman Hernaman ◽  
Rachmat Wiradimadja ◽  
Fransiskus Teguh Santoso
Keyword(s):  
Body Weight ◽  
Organic Matter ◽  
Feed Intake ◽  
Average Daily Gain ◽  
Feed Conversion ◽  
Organic Matter Digestibility ◽  
Daily Gain ◽  
Average Body ◽  
Average Body Weight

The experiments aimed to study about the performance and diet digestibility of male Garut lamb were a diet containing  Ipomea reptans seeds. Twenty two Garut sheeps at the age of 6-8 months with an average body weight of 16.17±1.33 kg were divided into four diet treatments containing 0%, 10%, 20%, and 30% Ipomea reptans seed and maintained for 10 weeks to measure the performance and digestibility of the diet. The study was conducted experimentally and the data collected and tested by Duncan’s test. The results showed that the use of Ipomea reptans seeds up to 30% increased (P<0.05) feed intake, average daily gain, dry and organic matter digestibility, but it had no effect on feed conversion. In Conclusion, the use of Ipomea reptans seed up to 30% yielded the best performance and diet digestibility and produced the same quality of diet.

scholarly journals Nutrient intake and quantitative aspects of carcass of finishing sheep fed with diets containing cashew nut meal

2012 ◽  
Vol 13 (4) ◽  
pp. 1099-1111 ◽  
Author(s):  
Emiliano Nunes do Nascimento ◽  
Marcos Cláudio Pinheiro Rogério ◽  
Ana Sancha Malveira Batista ◽  
Maria Socorro de Souza Carneiro ◽  
Angela Maria de Vasconcelos ◽  
...  
Keyword(s):  
Nutrient Intake ◽  
Control Diet ◽  
Average Daily Gain ◽  
Cashew Nut ◽  
Genetic Groups ◽  
Randomized Design ◽  
Completely Randomized Design ◽  
Daily Gain ◽  
Average Body ◽  
Average Body Weight

This work aimed to determine the nutrient intake and quantitative aspects of sheep carcass from three different genetic groups. Eighteen animals with initial average body weight of 20.1kg were used in a completely randomized design, in a factorial 3x2 scheme (three different crossbreeds - 6 F1Dorper x non defined breed, 6 F1Somalis x non defined breed and 6 F1Santa Inês x non defined breed versus two diets). The diets fed to the animals were formulated with or without cashew nuts. The inclusion of cashew nut meal in the diet influenced nutrient intake. Differences of intake among the animal groups were observed as higher intake for F1Dorper x non defined breed (NDB), followed by F1Somalis x NDB and for F1Santa Inês x NDB. However, the control diet produced no difference among these genotypes. The average daily gain was lower for both crossbreeds when cashew nut meal was added in the diets. The evaluated crossbreeds and diets did not affect the feed:gain ratio. The carcasses analyses showed that the inclusion of cashew nut meal in the diets reduced the cold carcass weight and the rib weight. The addition of cashew nut meal in the diets for lambs reduces food intake and carcass yield. The crossbreed F1Dorper x NDB presented the higher rate of average daily gain.

scholarly journals Dietary net energy levels for growing barrows from 30 to 70 kg

2022 ◽  
Vol 52 (7) ◽  
Author(s):  
Gabriela Puhl Rodrigues ◽  
Charles Kiefer ◽  
Karina Márcia Ribeiro de Souza Nascimento ◽  
Anderson Corassa ◽  
Danilo Alves Marçal ◽  
...  
Keyword(s):  
Body Weight ◽  
Phase I ◽  
Phase Ii ◽  
Block Design ◽  
Average Daily Gain ◽  
Carcass Characteristics ◽  
Linear Increase ◽  
The Other ◽  
Net Energy ◽  
Final Body Weight

ABSTRACT: This study evaluated the effect of dietary net energy (NE) levels on growth performance and carcass characteristics of barrows from 30 to 70 kg of body weight (BW). Sixty barrows with initial body weight (IBW) of 31.94 ± 3.54 kg and final body weight (FBW) of 71.98 ± 5.99 kg were allotted to one of five dietary NE levels (2.40, 2.45, 2.50, 2.55, and 2.60 Mcal kg-1), using a completely randomized block design with six replicates and two barrows per replicate. The experimental period was divided into phase I: 30 to 50 kg and phase II: 50 to 70 kg. The variables analyzed were average daily feed intake (ADFI), net energy intake (NEI), digestible lysine intake (LysI), average daily gain (ADG), feed conversion (FC), FBW, digestible lysine conversion:gain (LysI:G), Cost:Gain (C:G), loin eye area (LEA), muscle depth (MD), first backfat layer (BF1), second backfat layer (BF2), total backfat (BFt), lean meat percentage, and carcass bonus index (BI). In phase I, there was a linear increase (P < 0.05) in FBW, ADG, NEI, and LysI with increasing NE levels in the diet. In phase II, increasing dietary NE levels also increased (P < 0.05) FBW, ADG, NEI, LysI, and FC linearly. Overall, there was a linear increase (P < 0.05) in ADG, NEI, LysI, and FC with increasing NE levels in the diet. The other performance variables were not affected (P > 0.05) by the NE levels. There was an increase (P < 0.05) in BF2 with increasing NE levels, but the other carcass characteristics were not altered (P > 0.05). We recommended 2.60 Mcal of NE kg-1 in the diet for growing barrows from 30 to 70 kg.

scholarly journals A Comparison Effect Of feeding Barley or Soybean Meal Chemically Treated As A Source Of Undegradable Protein in Milk Production and Composition in Awassi Ewes: مقارنة تأثير التغذية على الشعير أو كسبة فول الصويا المعاملة كيمياويا  كمصدر للبروتين غير المتحلل في إنتاج الحليب وتركيبه في النعاج العواسية

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Omar Dheyaa Mohammed, Mohammed Najim Abdullah, Nadir Yousef
Keyword(s):  
Body Weight ◽  
Soybean Meal ◽  
Blood Glucose Concentration ◽  
Average Daily Gain ◽  
Blood Parameters ◽  
Barley Grain ◽  
Energy Yield ◽  
Daily Gain ◽  
Effect Of Feeding ◽  
Average Body

This study was conducted in animal research department at Ministry of Agriculture , by using 21 Awassi ewes with single lambs , after two weeks of birth , the average body weight 60.90 ± 1.92 kg and ages 3- 5 years. The ewes were divided into three groups , which was fed ad libitum on the experimental rations , first group (T1) was fed on control ration consist of barley grain , wheat bran , soybean meal and wheat straw which contained 13.46% crud protein , second (T2) and third (T3) group were fed on ration consist neither slow degradable barley grain nor slow degradable soybean meal as a source of undegradable protein and contained 16% crud protein , All ration was iso calorie and iso degradable protein. Results was indicated to a significant (p<0.05) increased in milk yield in T2 1504 g/day compared to T1 and T3 which was 1155 and 1151 g/ day, milk components dose not differed significantly between treatments , but it was noted significant increase in lactose yield 88.30 g/ day and energy yield 1229 kcal/ day in T2 compared T1 and T3 which were 65.33 , 67.29 g/ day and 874 , 881 kcal/ day respectively , the differences were not in final ewes body weight or in average daily gain of lambs , blood glucose concentration decreased (p<0.05) in T2 54.40 mg/dl as compared to T1 76.29 mg/ dl and T3 71.10 mg/ dl , while the differences were not significant in the other blood parameters.

scholarly journals Frequency of concentrate supplementation for grazing beef cattle

2017 ◽  
Vol 38 (4) ◽  
pp. 2141
Author(s):  
Ricardo Bonadimann ◽  
Eduardo Henrique Bevitori Kling de Moraes ◽  
Kamila Andreatta Kling de Moraes ◽  
Douglas Dos Santos Pina ◽  
André Soares de Oliveira ◽  
...  
Keyword(s):  
Beef Cattle ◽  
Rainy Season ◽  
Average Daily Gain ◽  
Production Performance ◽  
Brachiaria Brizantha ◽  
Concentrate Supplementation ◽  
Grazing Cattle ◽  
Daily Gain ◽  
Average Body ◽  
Average Body Weight

The objective of this study was to evaluate the effects of frequency of concentrate supplementation on the daytime feeding behavior (grazing, rumination, drinking, and idle times), production performance, and economic viability of grazing cattle in the rainy season. A total of 120 uncastrated Nellore animals with an average body weight (BW) of 382.5 ± 32.2 kg were allocated to palisadegrass (Brachiaria brizantha) paddocks for the experiment. We evaluated supplements provided in the amount of 2.0 kg/animal, supplied three times weekly (3tw) or daily (7X). Animals supplemented 3X (5.46%) spent more time (%) drinking water than those supplemented 7X (3.72%). Grazing time and animal performance were not influenced by the frequency of supplementation. Average daily gain was 1.00 and 1.02 kg/animal for the groups under 3X and 7X, respectively. Expenditures on transportation and labor are lower (43%) when animals are supplemented 3X. Supplementation provided three times per week does not affect the grazing time or the performance of beef cattle in the rainy season, but rather implies an expressive reduction of expenditures on labor and distribution of supplements.

Bewegungstherapie und körperliche Aktivität bei Patienten mit Herzinsuffizienz

Praxis ◽  
2018 ◽  
Vol 107 (17-18) ◽  
pp. 951-958 ◽  
Author(s):  
Matthias Wilhelm
Keyword(s):  
Phase I ◽  
Phase Ii ◽  
Körperliche Aktivität ◽  
Phase Iii

Zusammenfassung. Herzinsuffizienz ist ein klinisches Syndrom mit unterschiedlichen Ätiologien und Phänotypen. Die überwachte Bewegungstherapie und individuelle körperliche Aktivität ist bei allen Formen eine Klasse-IA-Empfehlung in aktuellen Leitlinien. Eine Bewegungstherapie kann unmittelbar nach Stabilisierung einer akuten Herzinsuffizienz im Spital begonnen werden (Phase I). Sie kann nach Entlassung in einem stationären oder ambulanten Präventions- und Rehabilitationsprogramm fortgesetzt werden (Phase II). Typische Elemente sind Ausdauer-, Kraft- und Atemtraining. Die Kosten werden von der Krankenversicherung für drei bis sechs Monate übernommen. In erfahrenen Zentren können auch Patienten mit implantierten Defibrillatoren oder linksventrikulären Unterstützungssystemen trainieren. Wichtiges Ziel der Phase II ist neben muskulärer Rekonditionierung auch die Steigerung der Gesundheitskompetenz, um die Langzeit-Adhärenz bezüglich körperlicher Aktivität zu verbessern. In Phase III bieten Herzgruppen Unterstützung.

THE EFFECT OF (Morinda citrifolia L.) MEAL IN DIET ON PERFORMANCE OF BROILER

2012 ◽  
Vol 2 (1) ◽  
pp. 21-27
Author(s):  
Yosi Fenita
Keyword(s):  
Body Weight ◽  
Body Weight Gain ◽  
Morinda Citrifolia ◽  
Feed Consumption ◽  
Feed Conversion ◽  
Randomized Design ◽  
Different Levels ◽  
Effect Of Feeding ◽  
Average Body ◽  
Average Body Weight

The objective of the research was to evaluate to effect of feeding mengkudu on performances of broilers. The research design used was completely randomized design. One hundred broilers were distributed into five treatments. The treatments were different levels of mengkudu meal (0, 0.75%, 1.5%, 2.25 % and 3%). The observed measured were feed consumption, average body weight (gain) and feed conversion. Results showed that feeding mengkudu (Morinda Citrifolia L.)  no effect significant (P>0.05) on feed consumption, average body weight and feed conversion.  In conclusion, feeding mengkudu meal up to 3% (in diet) does not negatively affect feed consumption, average body weight, and feed conversion.

scholarly journals The Effects of Feed Color on Broiler Performance between Day 1 and 21

Animals ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1511
Author(s):  
Joseph P. Gulizia ◽  
Kevin M. Downs
Keyword(s):  
Body Weight ◽  
Weight Gain ◽  
Treatment Effects ◽  
Body Weight Gain ◽  
Experimental Period ◽  
Feed Consumption ◽  
Feed Conversion ◽  
Broiler Performance ◽  
Average Body ◽  
Average Body Weight

Two trials were conducted to determine feed color effects on broiler performance. A completely randomized design was used. Trial 1 included four treatments: control (complete broiler starter diet), red, green, and blue; and Trial 2 included four treatments: control, orange, yellow, and purple. Each trial had 4 treatments with 4 replicates (60 birds/treatment) fed to 240 male Cobb 500 broilers during a 21 d grow out. Data were analyzed using the GLM procedure. In Trial 1, there were no treatment effects on average body weight, body weight gain, and feed consumption (p > 0.05). Adjusted feed conversion for control (1.23) was less than red (1.27; p = 0.001) and green (1.26; p = 0.009), with blue (1.25; p = 0.056) tending to be different during the experimental period. In Trial 2, there were no treatment effects on average body weight, feed consumption, and adjusted feed conversion during this study (p > 0.05). Body weight gain between d 1 to 14 for purple (490.78 g/bird) was more than orange (467 g/bird; p = 0.013) and yellow (461 g/bird; p= 0.004), with control (474 g/bird; p = 0.052) tending to be different. Results indicate that these feed colors had some, albeit limited, influence on broiler performance parameters.

scholarly journals AB0332 IMMUNOSUPPRESSIVE AND IMMONOMODULATING AGENTS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND THEIR CURRENT DEVELOPMENT STAGE

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1464.1-1465
Author(s):  
J. Blaess ◽  
J. Walther ◽  
J. E. Gottenberg ◽  
J. Sibilia ◽  
L. Arnaud ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systematic Review ◽  
B Cells ◽  
Phase I ◽  
Phase Ii ◽  
Clinical Development ◽  
Phase Iii ◽  
Jak Inhibitors ◽  
Exclusion Criteria ◽  
Immunomodulating Drugs

Background:Rheumatoid arthritis (RA) is the most frequent chronic inflammatory diseases with an incidence of 0.5% to 1%. Therapeutic arsenal of RA has continuously expanded in recent years with the recent therapeutic progress with the arrival of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), biological (bDMARDs) and targeted synthetic (tsDMARDs), JAK inhibitors. However, there are still some unmet needs for patients who do not achieve remission and who continue to worsen despite treatments. Of note, only approximately 40% of patients are ACR70 responders, in most randomized controlled trials. For these patients, finding new therapeutic avenues is challenging.Objectives:The objective of our study was to analyze the whole pipeline of immunosuppressive and immunomodulating drugs evaluated in RA and describe their mechanisms of action and stage of clinical development.Methods:We conducted a systematic review of all drug therapies in clinical development in RA in 17 databases of international clinical trials. Inclusion criterion: study from one of the databases using the keywords “Rheumatoid arthritis” (search date: June 1, 2019). Exclusion criteria: non-drug trials, trials not related to RA or duplicates. We also excluded dietary regimen or supplementations, cellular therapies, NSAIDs, glucorticoids or their derivatives and non-immunosuppressive or non-immunomodulating drugs. For each csDMARD, bDMARD and tsDMARD, we considered the study at the most advanced stage. For bDMARDs, we did not take into account biosimilars.Results:The research identified 4652 trials, of which 242 for 243 molecules met the inclusion and exclusion criteria. The developed molecules belong to csDMARDs (n=21), bDMARDs (n=117), tsDMARDs (n=105).Among the 21 csDMARDs molecules: 8 (38%) has been withdrawn, 4 (19%) are already labelled in RA (hydroxychloroquine, leflunomide, methotrexate and sulfasalazine) and 9 (43%) are in development: 1 (11%) is in phase I/II, 5 (56%) in phase II, 3 (33%) in phase IV.Among the 117 bDMARDs molecules: 69 (59%) has been withdrawn, 9 (8%) are labeled in RA (abatacept, adalimumab, anakinra, certolizumab, etanercept, golimumab, infliximab, rituximab, sarilumab, tocilizumab) and 39 (33%) are in development: 9 (23%) in phase I, 3 (8%) in phase I/II, 21 (54%) in phase II, 5 (12%) are in phase III, 1 (3%) in phase IV. bDMARDs currently under development target B cells (n=4), T cells (n=2), T/B cells costimulation (n=2),TNF alpha (n=2), Interleukine 1 or his receptor (n=3), Interleukine 6 or his receptor (n=7), Interleukine 17 (n=4), Interleukine 23 (n=1), GM-CSF (n=1), other cytokines or chemokines (n=5), integrins or adhesion proteins (n=3), interferon receptor (n=1) and various other targets (n=4).Among the 105 tsDMARDs molecules: 64 (61%) has been withdrawn, 6 (6%) JAK inhibitors, have just been or will probably soon be labelled (baricitinib, filgotinib, peficitinib, tofacitinib and upadacitinib), 35 (33%) are in development: 8 (24%) in phase I, 26 (74%) in phase II, 1 (3%) in phase III and. tsDMARDs currently under development target tyrosine kinase (n=12), janus kinase (JAK) (n=3), sphingosine phostate (n=3), PI3K pathway (n=1), phosphodiesterase-4 (n=3) B cells signaling pathways (n=3) and various other targets (n=10).Conclusion:A total of 242 therapeutic trials involving 243 molecules have been or are being evaluated in RA. This development does not always lead to new treatments since 141 (58%) have already been withdrawn. Hopefully, some of the currently evaluated drugs will contribute to improve the therapeutic management of RA patients, requiring a greater personalization of therapeutic strategies, both in the choice of molecules and their place in therapeutic sequences.Disclosure of Interests:Julien Blaess: None declared, Julia Walther: None declared, Jacques-Eric Gottenberg Grant/research support from: BMS, Pfizer, Consultant of: BMS, Sanofi-Genzyme, UCB, Speakers bureau: Abbvie, Eli Lilly and Co., Roche, Sanofi-Genzyme, UCB, Jean Sibilia: None declared, Laurent Arnaud: None declared, Renaud FELTEN: None declared

Sign in / Sign up

Export Citation Format

Share Document